Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–75
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically verified epithelial ovarian cancer
FIGO stage III-IV
Patients with measurable disease. RECIST criteria with GCIG modifications will be used for response and for progression assessment.
Lesions serving as measurable disease must have the longest diameter of greater than or equal to 20 mm as measured with conventional techniques or greater than or equal to 10 mm with spiral CT scan. Lesions measured by physical examination must have a longest diameter of greater than or equal to 20 mm.
You may not be if
Ovarian tumors with low malignant potential (borderline tumors)
Non-epithelial ovarian or mixed epithelial. non epithelial tumors (e.g. mixed Mullerian tumors)
Time between definitive surgery and enrollment into the study is greater than 6 weeks
Patients who have received previous chemotherapy or radiotherapy